FAP and cancer: As in primary tumors, myMAFs are the most abundant subtype, and either α‐SMA+, FAP+, or α‐SMA+/FAP+ myMAFs have been reported in brain metastasis from numerous cancer types, including lung carcinomas [104, 111].